SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 1,2,4-OXADIAZOLE DERIVATIVES - HIGHLY POTENT AND EFFICACIOUS AGONISTS FOR CORTICAL MUSCARINIC RECEPTORS

被引:130
作者
STREET, LJ
BAKER, R
BOOK, T
KNEEN, CO
MACLEOD, AM
MERCHANT, KJ
SHOWELL, GA
SAUNDERS, J
HERBERT, RH
FREEDMAN, SB
HARLEY, EA
机构
[1] Chemistry Department, Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, CM20 2QR, Terlings Park, Eastwick Road
[2] Biochemistry Department, Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, CM20 2QR, Terlings Park, Eastwick Road
关键词
D O I
10.1021/jm00172a003
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biochemical evaluation of novel 1,2,4-oxadiazole-based muscarinic agonists which can readily penetrate into the CNS is reported. Efficacy and binding of these compounds are markedly influenced by the structure and physicochemical properties of the cationic head group. In a series of azabicyclic ligands efficacy and affinity are influenced by the size of the surface area presented to the receptor, at the active site, and the degree of conformational flexibility. The exo-1-azanorbornane 16a represents the optimum arrangement, and this compound is one of the most efficacious and potent muscarinic agonists known. In a series of isoquinuclidine based muscarinic agonists efficacy and affinity are influenced by the geometry between the cationic head-group and hydrogen bond acceptor pharmacophore and steric bulk in the vicinity of the base. The anti configuration represented by 22a is optimal for muscarinic activity. Ligands with pKabelow 6.5 show poor binding to the muscarinic receptor as exemplified by the diazabicyclic derivative 42. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2690 / 2697
页数:8
相关论文
共 28 条
[1]   TOWARDS AN ANIMAL-MODEL FOR THE CHOLINERGIC LESION IN ALZHEIMERS-DISEASE [J].
ARCHER, T ;
FOWLER, CJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (02) :61-61
[2]   CONFORMATION OF ACETYLCHOLINE BOUND TO THE NICOTINIC ACETYLCHOLINE-RECEPTOR [J].
BEHLING, RW ;
YAMANE, T ;
NAVON, G ;
JELINSKI, LW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6721-6725
[3]   PHYSOSTIGMINE AND ARECOLINE - EFFECTS OF INTRAVENOUS INFUSIONS IN ALZHEIMER PRESENILE-DEMENTIA [J].
CHRISTIE, JE ;
SHERING, A ;
FERGUSON, J ;
GLEN, AIM .
BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (JAN) :46-50
[4]   RELATIVE AFFINITIES OF DRUGS ACTING AT CHOLINOCEPTORS IN DISPLACING AGONIST AND ANTAGONIST RADIOLIGANDS - THE NMS OXO-M RATIO AS AN INDEX OF EFFICACY AT CORTICAL MUSCARINIC RECEPTORS [J].
FREEDMAN, SB ;
HARLEY, EA ;
IVERSEN, LL .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (02) :437-445
[5]   DIRECT MEASUREMENT OF MUSCARINIC AGENTS IN THE CENTRAL-NERVOUS-SYSTEM OF MICE USING EXVIVO BINDING [J].
FREEDMAN, SB ;
HARLEY, EA ;
PATEL, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 174 (2-3) :253-260
[6]  
FREEDMAN SB, 1990, IN PRESS BR J PHARM
[7]  
FREEDMAN SB, UNPUB
[8]   NEUROTRANSMITTER DEFICITS IN ALZHEIMERS-DISEASE - CRITERIA FOR SIGNIFICANCE [J].
GREENWALD, BS ;
MOHS, RC ;
DAVIS, KL .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1983, 31 (05) :310-316
[9]   UNTERSUCHUNGEN IN DER CHINUCLIDIN-REIHE .3. 3-CHINUCLIDIN-CARBONSAURE [J].
GROB, CA ;
RENK, E .
HELVETICA CHIMICA ACTA, 1954, 37 (06) :1689-1698
[10]   NEUROPHARMACOLOGY OF DEGENERATIVE DISEASES ASSOCIATED WITH AGING [J].
GROWDON, JH .
MEDICINAL RESEARCH REVIEWS, 1983, 3 (03) :237-257